Publications
(212)Pb-radioimmunotherapy induces G(2) cell-cycle arrest and delays DNA damage repair in tumor xenografts in a model for disseminated intraperitoneal disease.
Yong KJ, Milenic DE, Baidoo KE, Brechbiel MW. Mol Cancer Ther. 2012 Mar;11(3):639-48.
PMID: 22238365
Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation.
Chen Y, Kornblit B, Hamlin DK, Sale GE, Santos EB, Wilbur DS, Storer BE, Storb R, Sandmaier BM. Blood. 2012 Feb 2;119(5):1130-8.
PMID: 22134165
Optimizing radioimmunoconjugate delivery in the treatment of solid tumor.
Huang CY, Pourgholami MH, Allen BJ. Cancer Treat Rev. 2012 Jan 4.
PMID: 22226242
Pre-Clinical Assessment of Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease.
Ray GL, Baidoo KE, Keller LM, Albert PS, Brechbiel MW, Milenic DE. Pharmaceuticals (Basel). 2011 Dec 22;5(1):1-15.
PMID: 22229017
Yttrium-90 (90Y) in the principal radionuclide therapies: an efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999-2009).
Goffredo V, Paradiso A, Ranieri G, Gadaleta CD. Crit Rev Oncol Hematol. 2011 Dec;80(3):393-410.
PMID:21388824
Clinical radioimmunotherapy-the role of radiobiology.
Pouget JP, Navarro-Teulon I, Bardiès M, Chouin N, Cartron G, Pèlegrin A, Azria D. Nat Rev Clin Oncol. 2011 Nov 8;8(12):720-34.
PMID: 22064461
Toxicity and relative biological effectiveness of alpha emitting radioimmunoconjugates.
Dahle J, Abbas N, Bruland ØS, Larsen RH. Curr Radiopharm. 2011 Oct;4(4):321-8.
PMID: 22202154
Experimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab.
Abbas N, Heyerdahl H, Bruland OS, Borrebæk J, Nesland J, Dahle J. EJNMMI Res. 2011 Aug 24;1(1):18.
PMID: 22214432
Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model.
Pagel JM, Kenoyer AL, Bäck T, Hamlin DK, Wilbur DS, Fisher DR, Park SI, Frayo S, Axtman A, Orgun N, Orozco J, Shenoi J, Lin Y, Gopal AK, Green DJ, Appelbaum FR, Press OW. Blood. 2011 Jul 21;118(3):703-11.
PMID: 21613259